Cannabis Tax Structures in Switzerland

This article is general information, not legal advice. Laws change; check current rules with official sources or a lawyer.

Three regulatory buckets: no unified tax code

Swiss cannabis tax rules depend entirely on which legal category a product falls into. There is no unified 'cannabis tax code'—instead, three separate regimes apply.

1. Low-THC CBD products (below 1.0% THC) fall outside the Narcotics Act (Betäubungsmittelgesetz, BetmG, SR 812.121) ^[1]. They are legal to sell but are taxed under the federal Tobacco Tax Act (Tabaksteuergesetz, TStG, SR 641.31) when marketed for smoking or as a tobacco substitute ^[2].

1. Medical cannabis has been available by ordinary prescription since 1 August 2022, after Parliament amended the BetmG to remove the previous exceptional-authorization requirement. It is dispensed through pharmacies and taxed like other prescription medicines.

1. Adult-use (recreational) cannabis remains prohibited under BetmG Art. 8, except within scientific pilot trials authorized under BetmG Art. 8a and the Ordinance on Pilot Trials (BetmPV, SR 812.121.5) ^[3]. These trials sell cannabis at controlled prices to registered participants.

CBD as a tobacco substitute: 25% federal levy

The Swiss Federal Office for Customs and Border Security (BAZG) classifies CBD hemp products sold as smokable flower, pre-rolls, or vape substitutes as 'tobacco substitutes' (Ersatzprodukte) under Art. 1 para. 2 TStG ^[2]. Strong evidence

The applicable rate is 25% of the retail selling price (Art. 10 TStG and the Tobacco Tax Ordinance) ^[2]. Importers and Swiss manufacturers must register with BAZG and pre-pay the tax before sale; retail prices already include this levy.

On top of the tobacco tax, standard VAT of 8.1% applies (raised from 7.7% on 1 January 2024) ^[4]. Strong evidence

CBD oils and other products marketed solely as cosmetics or food supplements are not classified as tobacco substitutes and therefore only carry VAT. However, food-supplement marketing may trigger separate food-safety regulation under the Federal Food Safety and Veterinary Office (FSVO/BLV), which many CBD products lack certification to satisfy.

The claim that 'CBD isn't really taxed in Switzerland because it's a wellness product' is incorrect. BAZG issued formal guidance in 2019 classifying smokable CBD as a tobacco substitute, and the agency has pursued back-tax claims against retailers who did not comply.

Medical cannabis: reduced VAT for prescriptions

Since 1 August 2022, physicians can prescribe cannabis-based medicines without a special Federal Office of Public Health (FOPH) permit. Dispensing occurs through licensed pharmacies.

Medicines authorized by Swissmedic and magistral (individually compounded) preparations dispensed on prescription are subject to the reduced VAT rate of 2.6% under Art. 25 para. 2 lit. a of the VAT Act (MWSTG, SR 641.20) ^[6]. Strong evidence

Reimbursement by mandatory health insurance (OKP/LAMal) remains limited as of October 2026. Most cannabis prescriptions are still paid out-of-pocket or reimbursed on a case-by-case basis under Art. 71a–71d KVV ^[7]. This is a coverage issue rather than a tax issue, but it is the primary reason patients continue to pay CHF 8–15 per gram equivalent. Advocacy for broader reimbursement is ongoing but has not yet resulted in systematic coverage.

Pilot trials: research pricing without excise tax

The pilot-trial ordinance (BetmPV) requires that cannabis sold in trials be priced to approximate the illicit market, so as not to distort participant behaviour, and that participants pay the full price themselves (Art. 15 BetmPV) ^[3]. Reported prices at trials such as Zurich's 'Züri Can' and Basel's 'Weed Care' have ranged from roughly CHF 8–12 per gram depending on THC content ^[8].

These prices include standard VAT (8.1%) but no cannabis-specific excise tax exists within the pilot regime Strong evidence. The trials are explicitly research projects conducted under temporary authorization, not a model for taxation. Adult-use cannabis remains illegal outside these trials.

For more detail on how the trials operate, see Switzerland's Cannabis Pilot Programs.

Future recreational regulation: still in preparation

A recreational excise tax regime would require new federal legislation. The Federal Council's post-consultation report of February 2024 indicated that regulatory work is ongoing but no bill has yet been drafted. Strong evidence

The Sub-Commission on Cannabis Regulation of the National Council's Health Commission (SGK-N) published a policy outline in 2023 recommending a state-controlled market with a THC-weighted excise tax, modelled on how alcohol is taxed by ethanol content. No rate, structure or implementation timeline has been legislated.

A 2022 study for the FOPH by researchers at Addiction Suisse and GREA projected hypothetical annual tax revenue between CHF 150 million and CHF 1 billion, depending on tax rate, price elasticity, and market size. Weak / limited This wide range reflects genuine uncertainty about elasticity and market behavior; anyone citing a specific 'expected Swiss cannabis tax rate' is speculating. The Federal Council has not proposed a rate.

Key takeaways and verification

This article is informational and is not legal or tax advice. Swiss cannabis tax law is administered federally (BAZG for tobacco tax, Federal Tax Administration/ESTV for VAT) but interacts with cantonal enforcement. If you import, sell, prescribe or otherwise handle cannabis products in Switzerland, consult a qualified Swiss lawyer or tax advisor and verify current rates directly with BAZG and ESTV.

Last verified: 31 October 2026.

Key items to re-check if you are reading this later: (a) whether the Federal Council has introduced a recreational cannabis bill; (b) the current standard and reduced VAT rates; (c) whether Swissmedic has authorized additional cannabis medicines that may change reimbursement eligibility; (d) whether BAZG has updated its guidance on CBD product classification; and (e) whether the pilot trials have been extended or replaced.

Sources

How this page was made

Related

• Cannabis Possession Limits in Switzerland — What Swiss law actually says about carrying cannabis, the 10-gram rule, and how pilot prog...
• Cannabis Social Equity Programs in Switzerland — Switzerland's pilot trials are public-health studies, not social equity or restorative-jus...
• Switzerland's Cannabis Pilot Programs — Government-authorized research trials distributing regulated cannabis to adult residents s...